Â鶹ÊÓƵ

UK pharma will grow despite the weight-loss challenge

FTSE 350 Review: UK pharma companies, not known for their weight-loss products, are prospering elsewhere

Telecoms stocks get ready for growth

FTSE 350 Review: The capital-intensive businesses have consolidated and are now growing their cash flows

AI starts testing media stocks’ digital moats

FTSE 350 Review: The sector is diverse, yet AI disruption fears are gripping almost every stock

Outsourcers keep winning despite political noise

FTSE 350 Review: Rising defence spending and strained public services are driving record bid pipelines for contractors

Software industry needs to face up to the AI challenge

FTSE 350 Review: The emergence of new bespoke tools is changing the way companies procure software

Too much uncertainty for medtech and healthcare companies

FTSE 350 Review: The sector’s premium rating continues to quietly wither away

Investors need to pick wisely with business services stocks

FTSE 350 Review: Not all companies need the cycle to turn, but the gap between quality and the rest is widening

What to expect from FTSE 350 stocks this year

Dan Jones explores the key themes, issues and opportunities for the sectors making up the London market